Biotechnology Risk-Assessment Governance In Russia.

1. Introduction

Biotechnology Risk-Assessment Governance in Russia refers to the legal, scientific, administrative and institutional framework through which the Russian Federation identifies, evaluates, controls and monitors potential risks arising from biotechnology research, genetic engineering, genetically modified organisms (GMOs), biological materials and biotechnology-derived products.

The principal objective is to ensure that biotechnology development does not create unacceptable risks to:

Human health and public safety.

Animals and plant populations.

Biodiversity and ecological systems.

Agricultural production and food security.

Biological and physical security.

Scientific research integrity.

The environment and future generations.

Russia's system combines preventive risk assessment, licensing, state registration, scientific examination, regulatory inspections and post-market monitoring.

An important distinction is that Russia does not have one comprehensive statute covering every biotechnology risk. Instead, risk governance operates through several federal laws, government resolutions, sanitary rules and administrative controls.

2. Constitutional and Legal Foundations

The Russian Constitution provides the general foundation for biotechnology risk governance.

Article 41 – Right to Health Protection

The state must protect public health and promote conditions that support access to healthcare. This provides a constitutional basis for regulating biotechnology that may create health risks.

Article 42 – Right to a Favourable Environment

Citizens have the right to a favourable environment, reliable information about its condition and compensation for environmental damage.

Article 45 – Protection of Rights

Individuals may protect their rights through legal and judicial mechanisms.

Article 46 – Judicial Protection

Individuals and organisations may challenge unlawful decisions and actions of public authorities before the courts.

These provisions are relevant where biotechnology research, GMO cultivation, biological manufacturing or environmental releases create risks requiring government intervention.

3. Principal Legislation Governing Biotechnology Risk Assessment

The following laws form the central legal framework.

LegislationRegulatory significance
Federal Law No. 86-FZ of 1996State regulation of genetic engineering
Federal Law No. 492-FZ of 2020Biological safety and biological-risk monitoring
Federal Law No. 52-FZ of 1999Sanitary and epidemiological safety
Federal Law No. 7-FZ of 2002Environmental protection
Federal Law No. 174-FZ of 1995Environmental impact assessment
Federal Law No. 3-FZ of 1996Radiation safety, where relevant to biotechnology facilities
Federal Law No. 61-FZ of 2010Circulation of medicines, including biological medicinal products

The two particularly important statutes are Federal Law No. 86-FZ and Federal Law No. 492-FZ.

CIS Legislation+2

 

4. Federal Law No. 86-FZ of 1996: State Regulation of Genetic Engineering

The Federal Law of 5 July 1996 No. 86-FZ, On State Regulation in the Field of Genetic Engineering Activities, is the principal legislation governing genetic-engineering risks.

Its purpose is to regulate activities that may affect human health, environmental protection and ecological safety.

A. Risk assessment obligations

Article 7 establishes the safety framework for genetic-engineering activities.

Organisations and individuals conducting genetic-engineering activities must undertake risk assessments when:

Planning biotechnology research.

Preparing experimental activities.

Conducting genetic-engineering operations.

Handling genetically modified organisms.

Undertaking activities that could affect human health or the environment.

Risk assessment is therefore not merely a final approval exercise. It is an obligation that applies throughout the relevant research and operational stages.

B. Biological and physical protection

The law requires appropriate biological and physical protection of:

Research personnel.

Surrounding populations.

Laboratories and research facilities.

The natural environment.

The level of protection must correspond to the potential harmful effects of the activity.

C. Registration and monitoring

Article 7 also provides for:

State registration of GMOs intended for environmental release.

Registration of relevant products obtained using GMOs or containing them.

Monitoring of effects on human health and the environment.

Regulatory supervision by authorised federal authorities.

Government intervention where monitoring identifies unacceptable risks.

Article 12 provides for legal responsibility where violations of genetic-engineering legislation cause harm or involve prohibited or unauthorised uses.

ГАРАНТ+2

5. Federal Law No. 492-FZ of 2020: Biological Safety Governance

The Federal Law of 30 December 2020 No. 492-FZ, On Biological Safety in the Russian Federation, establishes a broader national biological-safety framework.

It is particularly important because biotechnology risks can extend beyond individual laboratories.

Main objectives

Prevention of biological threats.

Identification of dangerous biological factors.

Monitoring of biological risks.

Protection of human, animal and plant health.

Environmental protection.

Coordination between public authorities.

Prevention of biological emergencies.

The law recognises biological risk in terms of the probability of harm, taking account of the seriousness of its consequences.

Application to biotechnology

Consider a biotechnology laboratory developing genetically modified microorganisms.

Its activities may create risks involving:

Accidental release.

Uncontrolled biological multiplication.

Exposure of laboratory workers.

Transmission of pathogenic agents.

Environmental contamination.

Unintended effects on other organisms.

The biological-safety framework provides the broader governmental context for identifying and managing these threats.

An important legal distinction is that Law No. 492-FZ is a general biological-safety statute. It does not replace the specific registration and risk-assessment requirements under Law No. 86-FZ.

CIS Legislation+1

6. Classification and Evaluation of Biotechnology Risks

Russian biotechnology governance uses risk-sensitive regulatory approaches.

For genetic-engineering activities, the statutory framework historically identifies four risk levels.

Risk levelGeneral descriptionRegulatory implications
Level IMinimal potential dangerBasic safety and organisational controls
Level IIInsignificant potential dangerAppropriate containment and safety procedures
Level IIIModerate potential dangerEnhanced containment and regulatory requirements
Level IVSignificant potential dangerStrict biological protection and licensing requirements where applicable

The classification is particularly important for genetic-engineering work involving microorganisms.

Activities involving microorganisms in closed systems beyond laboratory-research scale are assigned to Level III or IV under the statutory framework.

Open-system genetic-engineering activities are also subject to heightened risk classification.

Important qualification: The four-level classification should not be confused with a universal classification for every biotechnology product. Pharmaceutical products, clinical trials, agricultural GMOs and genetically engineered microorganisms may have additional, separate regulatory requirements.

FAOLEX+1

 

7. Institutional Governance and Regulatory Authorities

Russia distributes biotechnology risk-assessment responsibilities among several public institutions.

InstitutionPrincipal responsibilities
Ministry of HealthHealth regulation and coordination of relevant registration systems
RospotrebnadzorSanitary and epidemiological supervision and consumer protection
RosselkhoznadzorVeterinary and phytosanitary supervision, agricultural GMO controls
Ministry of Natural ResourcesEnvironmental policy and environmental protection
RosprirodnadzorEnvironmental supervision within its statutory jurisdiction
Ministry of Science and Higher EducationScientific policy and relevant scientific research governance

These authorities operate within their respective statutory jurisdictions.

For example, a biotechnology food product may require assessment of human-health risks, while a genetically modified agricultural organism intended for environmental release raises additional agricultural and environmental concerns.

The regulatory system therefore involves cooperation between scientific, health, environmental and agricultural institutions.

8. GMO Risk Assessment and State Registration

Russia applies a registration-based approach to relevant genetically modified organisms and products.

Government Resolution No. 35 of 18 January 2023 establishes the current principal registration procedure for GMOs intended for environmental release and products obtained using or containing such organisms.

The procedure replaced the earlier registration framework under Government Resolution No. 839 of 2013.

The registration framework includes:

A. Scientific information

Applicants must provide relevant information concerning the organism, its genetic modification and the intended use.

B. Safety examination

The assessment considers relevant scientific and safety information concerning the GMO and the product.

C. Registration decision

The responsible authorities determine whether the applicable registration requirements have been satisfied.

D. Registration certificate

Registration is documented through the prescribed state-registration mechanism.

E. Post-registration monitoring

The authorities monitor relevant effects on human health and the environment.

The Ministry of Health maintains the consolidated state register, while Rospotrebnadzor and Rosselkhoznadzor undertake monitoring within their respective areas of responsibility.

CIS Legislation+1

 

9. Food Safety and Scientific Risk Assessment

Biotechnology-derived food products require particular attention because scientific uncertainty may concern long-term health effects, allergenicity and nutritional composition.

Russia's GMO safety-assessment approach includes several scientific dimensions.

AssessmentMain purpose
Molecular assessmentExamine genetic construction and modification
Compositional assessmentCompare nutritional and biochemical characteristics
Toxicological assessmentIdentify possible toxic effects
Genotoxicological assessmentExamine potential genetic damage
Allergenicity assessmentIdentify possible allergic reactions
Technological assessmentEvaluate relevant processing characteristics
Identification testingDetect and quantify GMO material

The FAO's Russian Federation country profile identifies methodological guidance MU 2.3.2.2306-07 concerning the medical and biological safety assessment of plant GMOs.

It also identifies additional assessment possibilities where significant genomic, proteomic or metabolomic changes are detected.

This demonstrates the importance of scientific evidence in Russian biotechnology governance.

FAOHome

 

10. Environmental Risk Assessment and GMO Cultivation Restrictions

Environmental protection is an essential component of Russian biotechnology governance.

Three legislative instruments are particularly relevant.

A. Federal Law No. 7-FZ of 2002 – Environmental Protection

Article 50 establishes restrictions on the cultivation and breeding of plants and animals whose genetic programmes have been changed through genetic-engineering methods.

It provides an important statutory basis for controlling environmental exposure to GMOs, subject to the applicable exceptions for examinations and scientific research.

B. Federal Law No. 149-FZ of 1997 – Seed Production

The legislation restricts the import and use of genetically modified agricultural seeds for sowing, subject to exceptions for examinations and scientific research.

C. Federal Law No. 358-FZ of 2016

This law introduced significant amendments to Russian GMO regulation, including restrictions on the cultivation of genetically modified plants and animals and the import of genetically modified seeds for cultivation.

The combined effect is a regulatory distinction between scientific research involving GMOs and their commercial agricultural cultivation.

ГАРАНТ+2

11. Important Case Laws and Judicial Decisions

Russian biotechnology law has a relatively limited body of reported judicial decisions specifically addressing scientific risk-assessment methodologies.

Nevertheless, GMO enforcement cases provide important judicial guidance on registration, scientific evidence, environmental release and regulatory responsibility.

Case 1. Supreme Court of the Russian Federation – Agroholding KiPiAi

Direct biotechnology precedent

Case: Supreme Court of the Russian Federation, 19 September 2023, No. 9-АД23-12-К1.

Facts:

The dispute concerned an agricultural company using genetically modified rapeseed in the Nizhny Novgorod region.

During an inspection conducted on 24 August 2020, Rosselkhoznadzor identified the CP4 EPSPS genetic element in rapeseed material used on agricultural land.

The relevant agricultural areas included three fields covering approximately 394.92 hectares, 107.47 hectares and 47.37 hectares.

The authorities concluded that the company had used genetically modified material without the required state registration.

The company challenged the administrative decisions.

Legal issues:

Whether the use of unregistered GMOs violated Russian genetic-engineering legislation.

Whether laboratory testing could establish the presence of genetically modified material.

Whether the regulatory authorities had sufficient evidence to impose administrative liability.

Whether the agricultural company's conduct constituted an administrative offence.

Judgment:

The Supreme Court rejected the company's challenge and upheld the previous decisions.

The company remained subject to an administrative fine of 250,000 roubles under Article 6.3.1 of the Code of Administrative Offences.

Legal principles:

Relevant GMOs must satisfy applicable state-registration requirements.

Scientific testing results can constitute important evidence in GMO enforcement proceedings.

Organisations cannot disregard statutory restrictions on GMO use.

Regulatory compliance includes respecting the authorised purpose and conditions of GMO use.

Significance for risk-assessment governance:

This is particularly relevant because it demonstrates the relationship between scientific identification, regulatory registration and administrative enforcement.

However, the Court did not establish a comprehensive scientific methodology for GMO risk assessment. Its decision principally concerned the unlawful use of unregistered genetically modified material.

ГАРАНТ+1

Case 2. Russian GMO Cultivation Restrictions – Legislative Enforcement Framework

Relevant legislation: Federal Law No. 358-FZ of 3 July 2016, together with Article 50 of Federal Law No. 7-FZ.

Legal issue:

Whether genetically modified plants and animals could be commercially cultivated despite the statutory restrictions.

Legal significance:

The legislation establishes restrictions on cultivation and breeding, with exceptions for specified examinations and scientific research.

This framework is important for risk governance because it distinguishes controlled scientific experimentation from unrestricted environmental release.

Judicial qualification: This is a legislative authority, not a separate reported court judgment. It should therefore not be cited as an independent judicial precedent.

ГАРАНТ+1

Case 3. European Court of Human Rights – Roman Zakharov v. Russia

Case: Roman Zakharov v. Russia, Application No. 47143/06, Grand Chamber judgment, 4 December 2015.

Legal issue:

The case concerned surveillance powers and safeguards against arbitrary interference with private life under Article 8 of the European Convention on Human Rights.

Relevance to biotechnology:

This is not a biotechnology or GMO case. However, its principles concerning safeguards, supervision and protection against arbitrary state interference can provide comparative guidance when evaluating regulatory systems involving sensitive genetic information.

It should not be treated as a direct precedent governing laboratory biosafety or environmental GMO assessment.

12. Administrative and Civil Liability for Biotechnology Risks

Russian law provides several avenues for responsibility when biotechnology activities violate applicable safety requirements.

A. Administrative liability

Article 6.3.1 of the Russian Code of Administrative Offences addresses specified violations involving unregistered GMOs, unauthorised uses and breaches of special conditions.

The Supreme Court's 2023 Agroholding KiPiAi decision illustrates the practical application of this provision.

B. Civil liability

Where biotechnology activities cause injury or environmental damage, the relevant provisions of the Civil Code may apply.

Potential consequences include:

Compensation for personal injury.

Compensation for property damage.

Recovery of environmental damage.

Compensation for legally established losses.

Responsibility for defective or unsafe products.

C. Environmental liability

Federal Law No. 7-FZ provides the broader environmental-protection framework.

An organisation responsible for environmental harm may face restoration obligations and other statutory consequences.

D. Criminal liability

Where the facts satisfy the elements of an applicable criminal offence, relevant provisions of the Criminal Code may apply.

The existence of a biotechnology accident does not automatically establish criminal liability; the statutory elements, culpability and evidence must be demonstrated.

13. Precautionary Principle and Scientific Uncertainty

An important issue in biotechnology risk assessment is scientific uncertainty.

A genetically modified organism may produce effects that are not immediately detectable through ordinary laboratory testing.

Potential concerns include:

Unintended genetic effects.

Transfer of genetic material.

Changes in ecological relationships.

Possible allergenic effects.

Unanticipated environmental exposure.

Long-term effects on biodiversity.

The Russian statutory framework addresses these concerns through risk assessment, registration, containment, supervision and monitoring.

However, the precautionary principle should not be presented as a single unlimited statutory prohibition covering every biotechnology activity.

Its practical operation must be understood through the relevant environmental, sanitary and genetic-engineering provisions.

14. International Legal Framework

Russia's biotechnology risk governance also has an international dimension.

International instrumentRelevance
Convention on Biological Diversity, 1992Conservation of biodiversity
Cartagena Protocol on Biosafety, 2000International GMO biosafety framework
WHO biosafety guidanceLaboratory biological-risk management
Codex AlimentariusFood-safety risk assessment
WTO agreementsInternational biotechnology trade and sanitary measures

These instruments provide relevant international standards and comparative principles.

Their domestic legal effect depends on Russia's treaty participation, applicable implementation measures and the rules governing international agreements.

15. Major Legal Challenges in Russian Biotechnology Risk Governance

Several issues remain important for the development of Russian biotechnology law.

1. Scientific uncertainty

Risk assessment may be difficult where the long-term effects of genetically engineered organisms are not fully established.

2. Regulatory coordination

Multiple agencies may have overlapping responsibilities involving public health, agriculture and environmental protection.

3. Transparency

Access to reliable safety information is important for public confidence and accountability.

4. Emerging biotechnology

Existing GMO legislation may not address every regulatory question arising from synthetic biology, gene editing, gene drives and advanced cell technologies.

5. Cross-border biotechnology

Imported biological materials, research collaboration and international transfer of genetic information can create jurisdictional and compliance difficulties.

6. Post-market monitoring

Registration should not eliminate the need for continued monitoring where a biotechnology product or organism presents relevant ongoing risks.

7. Scientific independence

Regulatory decisions should be supported by reliable evidence, appropriate expertise and documented scientific reasoning.

16. Suggestions for Legal and Regulatory Reform

The following reforms could strengthen Russia's biotechnology risk-assessment governance:

Establish clearer risk-assessment criteria for emerging biotechnology.

Improve coordination among health, environmental and agricultural regulators.

Strengthen independent scientific evaluation.

Introduce more transparent procedures for communicating safety findings.

Improve environmental monitoring after authorised releases.

Develop specific guidance for gene-editing and synthetic-biology technologies.

Strengthen laboratory containment and emergency-response requirements.

Improve legal remedies for individuals affected by biotechnology-related harm.

Establish clearer procedures for reviewing and updating risk assessments when new scientific evidence emerges.

17. Conclusion

Biotechnology Risk-Assessment Governance in Russia is based on a combination of genetic-engineering regulation, biological-safety legislation, environmental protection, sanitary supervision and administrative enforcement.

Federal Law No. 86-FZ of 1996 provides the principal framework for genetic-engineering risk assessment. Federal Law No. 492-FZ of 2020 establishes broader biological-safety governance, while Federal Laws No. 7-FZ and No. 52-FZ address environmental and public-health protection.

The Supreme Court's decision in Agroholding KiPiAi, No. 9-АД23-12-К1 (2023), demonstrates that GMO registration requirements and scientific testing evidence can play a decisive role in administrative enforcement.

The central legal principle is that biotechnology research and commercial applications must comply with applicable safety, registration, monitoring and environmental-protection requirements.

Russia's system therefore treats biotechnology risk assessment as an ongoing regulatory responsibility rather than simply a one-time scientific approval.

18. Important Legal References for Academic Research

ReferenceSubject
Constitution of Russia, Articles 41, 42 and 46Health, environment and judicial protection
Federal Law No. 86-FZ (1996)Genetic engineering
Federal Law No. 492-FZ (2020)Biological safety
Federal Law No. 7-FZ (2002)Environmental protection
Federal Law No. 52-FZ (1999)Sanitary safety
Federal Law No. 358-FZ (2016)GMO restrictions
Federal Law No. 149-FZ (1997)Seed production
Government Resolution No. 35 (2023)GMO state registration
Code of Administrative Offences, Article 6.3.1GMO regulatory violations
Supreme Court, No. 9-АД23-12-К1 (2023)Unregistered GMO use

Useful research sources:

Federal Law No. 86-FZ – Genetic Engineering Regulation.

Federal Law No. 492-FZ – Biological Safety.

Government Resolution No. 35 – GMO Registration.

FAO – Russian Federation GMO Safety Assessment.

Supreme Court Judgment – No. 9-АД23-12-К1.

Academic note: This analysis distinguishes direct Russian biotechnology case law from broader comparative legal principles. For formal legal submissions, the latest consolidated Russian-language legislation and complete court judgments should be consulted.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT